Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Eton Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −1 vs. Q4 2021
- Shares held
- 5.78M
- +52.5K (+0.9%) vs. Q4 2021
- Total value
- $27.4M
- +$3.29M (+13.7%) vs. Q4 2021
- New holders
- 7
- 7 more added
- Sold out
- 8
- 10 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,379,275 | $10.4M | 3.22% | −5,725−0.2% | Reduced |
| Vanguard Group Inc | 872,871 | $3.81M | 0.00% | −5,531−0.6% | Reduced |
| Westside Investment Management, Inc. | 242,220 | $3.21M | 0.04% | +123,695+104.4% | Added |
| AWM Investment Company, Inc. | 472,588 | $2.06M | 0.27% | −27,412−5.5% | Reduced |
| Roumell Asset Management, LLC | 449,438 | $1.96M | 3.17% | 00.0% | Unchanged |
| BlackRock Inc. | 296,539 | $1.29M | 0.00% | −2,403−0.8% | Reduced |
| Bridgeway Capital Management, LLC | 225,163 | $982.0K | 0.02% | +21,900+10.8% | Added |
| Geode Capital Management, LLC | 186,971 | $815.0K | 0.00% | +11,118+6.3% | Added |
| Paradigm Capital Management Inc | 100,000 | $436.0K | 0.02% | +10,000+11.1% | Added |
| First Citizens Bank & Trust Co | 100,000 | $436.0K | 0.02% | +100,000 | New |
| State Street Corp | 91,603 | $399.0K | 0.00% | +7,831+9.3% | Added |
| Bank of New York Mellon Corp | 79,455 | $346.0K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 38,932 | $170.0K | 0.00% | −5,068−11.5% | Reduced |
| Northern Trust Corp | 30,355 | $132.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 28,071 | $122.0K | 0.00% | −2,001−6.7% | Reduced |
| Group One Trading, L.P. | 26,319 | $115.0K | 0.00% | −12,481−32.2% | Reduced |
| Gsa Capital Partners LLP | 24,475 | $107.0K | 0.01% | −15,342−38.5% | Reduced |
| JPMorgan Chase & Co | 24,273 | $106.0K | 0.00% | +24,273 | New |
| PDT Partners, LLC | 23,420 | $102.0K | 0.01% | +23,420 | New |
| Susquehanna Fundamental Investments, LLC | 21,269 | $93.0K | 0.00% | −7,292−25.5% | Reduced |
| Goldman Sachs Group Inc | 17,610 | $77.0K | 0.00% | +17,610 | New |
| Chicago Trust Co NA | 16,700 | $73.0K | 0.02% | 00.0% | Unchanged |
| Financial Advisors Network, Inc. | 10,633 | $46.0K | 0.01% | 00.0% | Unchanged |
| Belvedere Trading LLC | 10,876 | $43.0K | 0.03% | +10,876 | New |
| Wells Fargo & Company | 7,624 | $34.0K | 0.00% | +7,500+6,048.4% | Added |
| UBS Group AG | 4,555 | $20.0K | 0.00% | +476+11.7% | Added |
| Tower Research Capital LLC (TRC) | 1,338 | $6.00K | 0.00% | +1,338 | New |
| Plante Moran Financial Advisors, LLC | 1,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 350 | $1.53K | 0.00% | −358−50.6% | Reduced |
| Lindbrook Capital, LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 23 | $0 | 0.00% | +23 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −92,092−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −42,240−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −22,642−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −20,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −17,593−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −15,190−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,212−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −328−100.0% | Sold out |